Pharma
Dr Reddys Laboratories Ltd
DRREDDY · NSE · INE089A01031Monday, 26 Oct 20263:28 pm
Market Cap₹1,09,208 Cr
P/E39.0
P/B2.8
EPS₹33.59
Div Yield0.6%
ROE11.6%
ROCE13.5%
ROE11.6%
1Y Return+0.60%
Avg. Volume1.4M
Price Chart
52-Week Range
About
Dr Reddys Laboratories Ltd is a Pharma company listed on NSE.
Technicals
Free account
Register freeTechnicals
Create a free account to view momentum, moving averages, and delivery signals.
Quant
Premium
UpgradeQuant metrics
Upgrade to view volatility, drawdown, factor, and risk metrics.
Key Ratios
Market Cap₹1,09,208 Cr
Current Price₹1,310.9
52W High / Low₹1,414.9 / ₹1,101
Stock P/E39.0
Price to Book2.8
EPS (TTM)₹33.59
Dividend Yield0.6%
ROE11.6%
1Y Return+0.60%
Day Change+6.62%
Profit & Loss
| Period | TTM | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹33,228 Cr | ₹33,700 Cr | ₹32,644 Cr | ||||||||||
| Expenses | ₹28,088 Cr | ₹27,247 Cr | ₹24,097 Cr | ||||||||||
| Operating Profit | ₹5,140 Cr | ₹6,454 Cr | ₹8,547 Cr | ||||||||||
| OPM % | 15.0% | 19.0% | 26.0% | ||||||||||
| Other Income | ₹1,437 Cr | ₹1,372 Cr | ₹1,119 Cr | ||||||||||
| Depreciation | ₹2,119 Cr | ₹2,059 Cr | ₹1,704 Cr | ||||||||||
| Interest | ₹416 Cr | ₹374 Cr | ₹283 Cr | ||||||||||
| Profit Before Tax | ₹4,041 Cr | ₹5,393 Cr | ₹7,680 Cr | ||||||||||
| Tax | ₹858 Cr | ₹1,235 Cr | ₹1,955 Cr | ||||||||||
| Net Profit | ₹3,183 Cr | ₹4,158 Cr | ₹5,725 Cr | ||||||||||
| EPS (₹) | 38.6 | 50.3 | 67.8 | ||||||||||
| Dividend Payout % | — | 16% | 12% |
Financial history locked
Register freeRegister free to see 10 more years.
Quarterly Results
| Quarter | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹8,100 Cr | ₹7,546 Cr | ₹8,753 Cr | ₹8,828 Cr | |||||||||
| Expenses | ₹7,240 Cr | ₹7,164 Cr | ₹6,866 Cr | ₹6,818 Cr | |||||||||
| Operating Profit | ₹860 Cr | ₹382 Cr | ₹1,888 Cr | ₹2,010 Cr | |||||||||
| OPM % | 11.0% | 5.0% | 22.0% | 23.0% | |||||||||
| Depreciation | ₹537 Cr | ₹557 Cr | ₹521 Cr | ₹505 Cr | |||||||||
| Interest | ₹126 Cr | ₹106 Cr | ₹94 Cr | ₹91 Cr | |||||||||
| Net Profit | ₹436 Cr | ₹221 Cr | ₹1,190 Cr | ₹1,337 Cr | |||||||||
| EPS (₹) | 5.3 | 2.7 | 14.5 | 16.1 |
Quarterly history locked
Register freeRegister free to see 9 more quarters.
Balance Sheet
| Period | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹84 Cr | ₹83 Cr | ₹83 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹37,808 Cr | ₹33,466 Cr | ₹28,171 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹7,734 Cr | ₹4,677 Cr | ₹2,002 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹10,951 Cr | ₹9,797 Cr | ₹8,524 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹56,577 Cr | ₹48,023 Cr | ₹38,780 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹22,063 Cr | ₹18,226 Cr | ₹10,426 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹5,285 Cr | ₹4,051 Cr | ₹4,930 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹27,768 Cr | ₹23,280 Cr | ₹22,004 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹56,577 Cr | ₹48,023 Cr | ₹38,780 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance sheet history locked
Register freeRegister free to see 10 more years.
Cash Flow
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| FY26 | ₹5,674 Cr | ₹-6,425 Cr | ₹829 Cr | ₹78 Cr |
| FY25 | ₹4,643 Cr | ₹-5,785 Cr | ₹1,891 Cr | ₹749 Cr |
| FY24 | ₹4,543 Cr | ₹-4,034 Cr | ₹-376 Cr | ₹133 Cr |
| FY23 | ||||
| FY22 | ||||
| FY21 | ||||
| FY20 | ||||
| FY19 | ||||
| FY18 | ||||
| FY17 | ||||
| FY16 | ||||
| FY15 |
Cash flow history locked
Register freeRegister free to see 10 more years.
Peer Comparison
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| 3B BlackBio Dx Ltd | ₹1,210 Cr | 21.4 | +20.2% | +17.9% |
| Aarey Drugs & Pharmaceuticals Ltd | ₹353 Cr | 75.3 | +2.75% | +59.84% |
| Aarti Drugs Ltd | ₹3,429 Cr | 18.0 | +13.37% | +11.57% |
| Aarti Pharmalabs Ltd | ₹7,495 Cr | 35.2 | +8.51% | +14.26% |
| Abbott India Ltd | — | — | +34.46% | -7.16% |
Mutual Fund Holdings
Free account
Register freeMutual fund holdings
Create a free account to see institutional ownership snapshots.
Bulk & Block Deals
Free account
Register freeBulk & block deals
Create a free account to view recent institutional deal activity.
Analyst Estimates
Free account
Register freeAnalyst estimates
Create a free account to view analyst estimate summaries.
Latest News
2026-10-25Dr Reddy's Laboratories Ltd (RDY) (Q2 2027) Earnings Call Highlights: Margin Recovery in Focus ...GuruFocus.com2026-10-23Dr. Reddy's Laboratories Q2 Earnings Call HighlightsMarketBeat2026-10-14Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015BSE Filing2026-07-28Dr Reddy's Laboratories Ltd (RDY) Q1 2027 Earnings Call Highlights: Navigating Challenges and ...GuruFocus.com2026-07-22Dr. Reddy's Laboratories Q1 Earnings Call HighlightsMarketBeat
Documents & Filings
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.